Masayo Tada - Desert Peak President
President
Mr. Masayo Tada was serving as Chairman of the Board and Representative Director in Sumitomo Dainippon Pharma Co., Ltd. since April 1, 2018. His previous titles include Chief Director of Overseas Business, Executive Vice President and Senior Managing Executive Officer in the Company. Prior to joining the Company, he used to work for its parent company, Sumitomo Chemical Co., Ltd. He obtained a Bachelor degree in Economics from The University of Tokyo in March 1968. since 2018.
| Age | 72 |
| Tenure | 6 years |
| Phone | 303-595-3331 |
| Web | http://www.dcppartners.com |
Desert Peak Management Efficiency
The company has Return on Asset of 0.02 % which means that on every $100 spent on assets, it made $0.02 of profit. This is way below average. Desert Peak's management efficiency ratios could be used to measure how well Desert Peak manages its routine affairs as well as how well it operates its assets and liabilities.The company has 2.42 B in debt with debt to equity (D/E) ratio of 0.83, which is OK given its current industry classification. Desert Peak Minerals has a current ratio of 1.0, demonstrating that it is not liquid enough and may have problems paying out its financial commitments when the payables are due. Debt can assist Desert Peak until it has trouble settling it off, either with new capital or with free cash flow. So, Desert Peak's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Desert Peak Minerals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Desert to invest in growth at high rates of return. When we think about Desert Peak's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Robert Campbell | NiSource | 55 | |
| Michael Finissi | NiSource | 55 | |
| Mike Finissi | NiSource | N/A | |
| Michael Hooper | NiSource | N/A | |
| Mukesh Mehta | AssetMark Financial Holdings | 57 | |
| Pablo Vegas | NiSource | 47 | |
| Randy Hulen | NiSource | 61 | |
| David Leon | Alliant Energy Corp | 61 | |
| Joseph Mulpas | NiSource | 45 | |
| Mark Kempic | NiSource | N/A | |
| Nestor Martin | Transportadora de Gas | 65 | |
| John Larsen | Alliant Energy Corp | 60 | |
| Carlos Sidero | Transportadora de Gas | 68 | |
| Wayne Reschke | Alliant Energy Corp | 61 | |
| Shawn Anderson | NiSource | 42 | |
| Carrie Hightman | NiSource | 61 | |
| Alejandro Basso | Transportadora de Gas | 63 | |
| Martin Loeser | Silvercrest Asset Management | N/A | |
| Donald Brown | NiSource | 52 | |
| Oscar Sardi | Transportadora de Gas | 69 | |
| Vincent Parisi | NiSource | 56 | |
Management Performance
| Return On Asset | 0.02 |
Desert Peak Minerals Leadership Team
Elected by the shareholders, the Desert Peak's board of directors comprises two types of representatives: Desert Peak inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Desert. The board's role is to monitor Desert Peak's management team and ensure that shareholders' interests are well served. Desert Peak's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Desert Peak's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Nobuhiko Tamura, Managing Executive Officer | ||
| Kazuo Koshiya, Executive Officer | ||
| Wouter Kempen, Chairman of DCP Midstream GP LLC and CEO of DCP Midstream GP LLC | ||
| Saeko Arai, Independent Director | ||
| Masayo Tada, President Executive President Representative Director | ||
| Hideyuki Harada, Executive Officer, Chief Director of Research | ||
| Makoto Hara, Senior Managing Executive Officer, Director | ||
| Hitoshi Odagiri, Executive Officer, Director of Human Resources | ||
| Yutaka Atomi, Independent Director | ||
| Yoshinori Ohe, Managing Executive Officer, Chief Director of Reliability Guarantee | ||
| Kazuhiro Takada, Executive Officer, Director of Corporate Governance | ||
| Yoshihiro Okada, Managing Executive Officer, Chief Director of Production, Director | ||
| Hajime Kinuta, Executive Officer, Director of Business Planning | ||
| Guy Buckley, Director | ||
| Susumu Nakajima, Managing Executive Officer, Chief Director of Sales | ||
| Hiroyuki Baba, Executive Officer | ||
| Toru Kimura, Executive Officer, Manager of Regeneration & Cell Medicine Business Promotion Office | ||
| Brian Mandell, Director of DCP Midstream GP, LLC | ||
| Patricia Andrews, Executive Officer, CEO of Subsidiary | ||
| Allen Capps, Director | ||
| Hiroshi Sato, Independent Director | ||
| William Kimble, Independent Director of DCP Midstream GP, LLC | ||
| Hidehiko Sato, Independent Director | ||
| Fred Fowler, Independent Director of DCP Midstream GP, LLC | ||
| Yoshiharu Ikeda, Executive Officer, Chief Director of Technology Research | ||
| Michael Richards, VP of DCP Midstream GP LLC, General Counsel of DCP Midstream GP LLC and Secretary of DCP Midstream GP LLC | ||
| Hiroshi Noguchi, Executive Vice President Chief Director of Research, Representative Director | ||
| Robert Fiedorek, Director of DCP Midstream GP, LLC | ||
| Nobuyuki Hara, Executive Officer, Chief Director of Development | ||
| Billy Waycaster, Independent Director of DCP Midstream GP, LLC | ||
| Sean OBrien, CFO of DCP Midstream GP LLC and Group VP of DCP Midstream GP LLC | ||
| John Zuklic, Director of DCP Midstream GP, LLC | ||
| Hisayoshi Kashima, Director of Accounting | ||
| Masaru Ishidahara, Managing Executive Officer, Director | ||
| Chiang Li, Executive Officer | ||
| Mitsuyuki Taniguchi, Executive Officer, Deputy Chief Director of Sales | ||
| Hiroshi Nomura, Managing Executive Officer, Director | ||
| Atsuko Higuchi, Executive Officer | ||
| Shigeyuki Nishinaka, Executive Officer, Director of Business Development | ||
| Andrea Attel, IR Contact Officer | ||
| Antony Loebel, Executive Officer |
Desert Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Desert Peak a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | 0.02 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 5.26 B | |||
| Shares Outstanding | 114.6 M | |||
| Shares Owned By Insiders | 19.60 % | |||
| Shares Owned By Institutions | 69.00 % | |||
| Number Of Shares Shorted | 2.4 M | |||
| Price To Earning | 21.93 X | |||
| Price To Book | 1.68 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Desert Peak in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Desert Peak's short interest history, or implied volatility extrapolated from Desert Peak options trading.
Pair Trading with Desert Peak
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Desert Peak position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Desert Peak will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Edwards Lifesciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Edwards Lifesciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Edwards Lifesciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Edwards Lifesciences Corp to buy it.
The correlation of Edwards Lifesciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Edwards Lifesciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Edwards Lifesciences Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Edwards Lifesciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Consideration for investing in Desert Stock
If you are still planning to invest in Desert Peak Minerals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Desert Peak's history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |